Virtus LifeSci Biotech Clinical Trials ETF (BBC) Price, Holdings, & News

ETF Overview

The Virtus LifeSci Biotech Clinical Trials ETF (BBC) is an exchange-traded fund that mostly invests in health care equity. The fund tracks an equally weighted index of US-listed biotech companies with lead drugs in various phases of clinical trials. BBC was launched on Dec 16, 2014 and is managed by Virtus.

Key Stats

• Today's Range: $24.77 to $24.92
• 50-Day Range: $23.82 to $31.45
• 52-Week Range: $23.51 to $31.99
• Volume: 1,115 shs
• Average Volume: 1,358 shs
• Market Capitalization: $9.97 million
• Assets Under Management: $8.74 million
• Dividend Yield: 0.30%
• Net Expense Ratio: 0.79%
• Aggregate Rating: Moderate Buy

BBC ETF - Frequently Asked Questions

How have BBC shares performed this year?

Virtus LifeSci Biotech Clinical Trials ETF's stock was trading at $23.94 on January 1st, 2025. Since then, BBC shares have increased by 4.1% and is now trading at $24.92.
View the best growth stocks for 2025 here.

How do I buy shares of Virtus LifeSci Biotech Clinical Trials ETF?

Shares of BBC stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

What other stocks do shareholders of Virtus LifeSci Biotech Clinical Trials ETF own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Virtus LifeSci Biotech Clinical Trials ETF investors own include NVIDIA (NVDA), Broadcom (AVGO), Adobe (ADBE), Arista Networks (ANET), Meta Platforms (META), e.l.f. Beauty (ELF) and General Electric (GE).

Fund Details

• Issuer: Virtus
• Fund Name: Virtus LifeSci Biotech Clinical Trials ETF
• Tax Classification: Regulated Investment Company
• Stock Exchange: NYSEARCA
• Current Symbol: NYSEARCA:BBC
• Inception Date: 12/16/2014
• Fund Manager: Matthew B. Brown, Seth Kadushin
• Web: N/A
• Phone: N/A

Fund Focus

• Asset Class: Equity
• Benchmark: LifeSci Biotechnology Clinical Trials Index
• Category: Sector
• Focus: Health Care
• Development Level: Developed Markets
• Region: North America
• Number of Holdings: 126

Fund Statistics

• Assets Under Management: $8.74 million
• Average Daily Volume: $2,795.70
• Discount/Premium: -0.04%

Administrator, Advisor and Custodian

• Administrator: Virtus ETF Solutions, LLC
• Advisor: Virtus ETF Advisers LLC
• Custodian: The Bank of New York Mellon Corporation
• Distributor: ETF Distributors LLC
• Transfer Agent: The Bank of New York Mellon Corporation
• Trustee: N/A
• Lead Market Maker: Virtu Financial

Options

• Optionable: N/A
• Short Interest: 5,500 shs

Miscellaneous

• Outstanding Shares: 400,004
• Beta: 1.22
• Creation Unit: 50,000
• Creation Fee: $500.00